NuVasive (NASDAQ:NUVA) Receives New Coverage from Analysts at StockNews.com
StockNews.com assumed coverage on shares of NuVasive (NASDAQ:NUVA – Free Report) in a research report released on Tuesday morning. The brokerage issued a hold rating on the medical device company’s stock. Several other brokerages also recently commented on NUVA. Barclays boosted their target price on NuVasive from $56.00 to $58.00 and gave the stock an […]